Dr Reddy's Laboratories reported a 22% year-on-year increase in Q4FY25 consolidated net profit to ₹1,594 crore, surpassing estimates. Revenue rose 20% to ₹8,506 crore, exceeding the projected ₹7,083 crore from the previous year.
2 min read9 May 2025Sigachi Industries shares jumped 5% from their intraday low on Monday's stock market session after the company announced an MoU update related to a drug delivery technology.
1 min read28 Apr 2025Stock Market Today: With 250% rally in one year the Multibagger pharma stock gained further on the BSE on Friday, during the intraday trades despite stock market crash. The Sudarshan Pharma Industries had reported its financial performance for the quarter ending March'2025
1 min read25 Apr 2025Shares of Venus Remedies rose 14.3% to ₹356.65 after the US FDA granted QIDP designation to its product VRP-034, targeting bloodstream infections. This designation offers regulatory benefits, highlighting the need for safer polymyxin therapies. The stock has rebounded 12% this month.
1 min read17 Apr 2025ICICI Prudential Mutual Fund acquired 83,71,114 shares of Gland Pharma, holding a 5.08% stake. Following this, Gland Pharma's share price rose 0.8% to ₹1439, marking three consecutive days of gains despite a 10% decline in April due to tariff concerns.
2 min read16 Apr 2025Pharma Stocks; The Indian pharma market experienced a robust growth of 9.3% year-on-year in March 2025, with key players like Cipla, Sun, Ipca Labs, and JB Pharma leading the charge. This marks a significant improvement compared to the previous year. Discover the driving factors behind this surge.
1 min read14 Apr 2025Gland Pharma share price declined as much as 5.99%, Aurobindo Pharma stock price declined nearly 5%, while Biocon shares plunged over 4%.
1 min read9 Apr 2025Sun Pharma share price has seen a 10% decline in year-to-date (YTD) performance and an 11% drop over the past six months. However, the stock has delivered a strong 74% return in two years and a remarkable 352% gain over five years, reflecting its long-term strength.
3 min read4 Apr 2025Despite the 26% tariff imposed by the US, India showed resilience with only a 0.40% decline in markets, while regional peers suffered bigger losses. Analysts believe India's IT and pharma sectors remain largely unaffected, suggesting potential for negotiation and macroeconomic recovery.
4 min read3 Apr 2025The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared